A Review of Hereditary Colorectal Cancers
- PMID: 30855783
- Bookshelf ID: NBK538195
A Review of Hereditary Colorectal Cancers
Excerpt
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the third leading cause of cancer-related deaths in the United States. CRC is the leading cause of cancer deaths in men aged 50 or younger and the second leading cause in women of the same age group, following breast cancer. CRC is almost always preceded by adenomatous or serrated colon polyps. About 65% of CRC cases are sporadic, 25% are associated with a family history of CRC or adenomatous polyps in first-degree relatives, and the remaining 10% are attributed to hereditary (genetic) CRC syndromes.
The risk of CRC is approximately twice as high in individuals with a family history of CRC compared to those without such a history. Hereditary CRC syndromes result from specific genetic mutations that increase susceptibility to CRC, as well as other malignancies and benign conditions. Familial adenomatous polyposis (FAP) and Lynch syndrome, also referred to as hereditary nonpolyposis CRC (HNPCC), are the most prevalent hereditary CRC syndromes. These conditions are generally more aggressive, have a poorer prognosis, and may be less responsive to chemotherapy compared to sporadic CRC.
A genetic or hereditary cause of CRC should be suspected and investigated if one or more of the following factors are present:
A significant family history of CRC or premalignant colon polyps in 2 or more first-degree relatives of the proband.
A family history of other cancers known to be associated with hereditary CRC, particularly endometrial cancer.
Onset of CRC at an unusually early age.
Multiple primary cancers in an individual, including CRC.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Surgical Oncology
- Radiation Oncology
- Medical Oncology
- Prognosis
- Complications
- Deterrence and Patient Education
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, Hopper JL. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol. 2006 Feb;59(2):114-24. - PubMed
-
- PDQ Cancer Genetics Editorial Board. PDQ Cancer Information Summaries [Internet] National Cancer Institute (US); Bethesda (MD): 2025. Mar 21, Genetics of Colorectal Cancer (PDQ®): Health Professional Version.
-
- Kastrinos F, Samadder NJ, Burt RW. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer. Gastroenterology. 2020 Jan;158(2):389-403. - PubMed
-
- Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous